Top 5 Low Price Companies To Buy Right Now

��p, like a rocket ship,

Down, Like a roller coaster��/p>

Lyrics from Palisades Park

Palisades Park, located in Northern New Jersey, was an amusement park that opened in 1898 and closed in 1971, but not before gaining acclaim in a song written by Chuck Barris (yes, the Gong Show host) and sung by Freddy "Boom-Boom" Cannon. In 1962 the song reached number three on the Billboard Top 100. It was covered by everyone from The Beach Boys to The Ramones and was even performed live by Bruce Springsteen and The E Street Band.

Before the song hit the charts I was very familiar with Palisades Park. I grew up seeing commercials for it on television and being bombarded with their radio ads all summer long. Admissions were free and the rides were a nickel during the day and a dime at night. Even the low prices, the commercials and that song weren't enough to keep the park open.

Major amusement parks are quite different today. You typically buy one ticket to gain entrance to the park and then all the rides and shows are free. One company that owns many one-ticket amusement parks is Cedar Fair, LP (FUN). It is a limited partnership with an attractive distribution that operates nearly a dozen amusement parks, with several in Ohio and California. Knott's Berry Farm, near Los Angeles, is located not far from SeaWorld, Universal Studios and the Walt Disney Co.'s (DIS) Disneyland. Dorney Park in Eastern Pennsylvania faces competition from Hershey Park, Sesame Place and to a lesser extent, Great Adventure. Other parks face less competition and are located in Canada, Virginia, Minnesota and elsewhere. It also owns 5 hotels.

5 Best Heal Care Stocks To Buy Right Now: Hyperion Therapeutics Inc (HPTX)

Hyperion Therapeutics, Inc. (Hyperion), incorporated in November 2006, is a development-stage biopharmaceutical company focused on the development and commercialization of novel therapeutics to treat disorders in the areas of orphan diseases and hepatology. The Company develops Ravicti (glycerol phenylbutyrate) to treat the prevalent urea cycle disorders (UCD) and hepatic encephalopathy (HE). The Company has completed two Phase II trials and one pivotal Phase III trial of Ravicti. The Company�� HE clinical program consists of two trials, which have enrolled patients with cirrhosis. On December 23, 2011, the Company submitted a new drug application (NDA) for Ravicti for the chronic management of UCD in patients aged six years and above based on data from its pivotal Phase III trial in adult patients and the results of two Phase II trials, one in adults and one in pediatric patients aged 6 through 17 years. In June 2013, Hyperion Therapeutics Inc announced that the completion of its acquisition of BUPHENYL (sodium phenylbutyrate) Tablets and Powder from Ucyclyd Pharma Inc., a subsidiary of Valeant Pharmaceuticals International, Inc.

In June 2011, the Company completed a 24-month carcinogenicity study of Ravicti in rats. On March 22, 2012, pursuant to an asset purchase agreement (purchase agreement) with Ucyclyd Pharma, Inc., a wholly owned subsidiary of Medicis Pharmaceutical Corporation, the Company purchased all of the worldwide rights to Ravicti. The Company also has an option to acquire all of Ucyclyd�� worldwide rights in BUPHENYL and AMMONUL (sodium phenylacetate and sodium benzoate) injection.

The Company conducted a pivotal Phase III trial of Ravicti in adult patients 18 years of age or older with UCD. The Company completed a second Phase II trial at five centers in North America in UCD patients aged 6 through 17 years. This trial includes two phases: a two-week, open-label, safety, tolerability, pharmacokinetic characteristics and ammonia control of Ravicti. The Co! mpany enrolled 77 adult and pediatric UCD patients in its two 12-month open-label safety studies, 69 of whom completed the studies. The Company conducted nonclinical genotoxicity and carcinogenicity studies to assess the tumorigenic potential of Ravicti in animals and to assess the relevant risk in humans. The Company is conducting a Phase II multi-center study of patients with cirrhosis and episodic HE.

Advisors' Opinion:

• [By Sean Williams]

  What: Shares of Hyperion Therapeutics (NASDAQ: HPTX  ) , a biopharmaceutical company focused on treatments for orphan diseases and hepatology, rose as much as 10% after receiving orphan drug exclusivity status for Ravicti from the Food and Drug Administration, and exercising an option to acquire two additional urea cycle drugs from Valeant Pharmaceuticals (NYSE: VRX  ) .

• [By Jesse Solomon]

  NPS Pharmaceuticals (NPSP), for example, created a drug for treating short bowel syndrome. And Hyperion Therapeutics (HPTX) is developing a drug for hepatic encephalopathy, a decline of brain function that according to the National Institute of Health occurs when the liver is no longer able to remove toxins from the blood. Those stocks are up 20% and 40%, respectively, this year.

Top 5 Low Price Companies To Buy Right Now: Nanometrics Incorporated(NANO)

Nanometrics Incorporated provides high-performance process control metrology systems used primarily in the fabrication of integrated circuits, high-brightness LEDs, data storage devices, and solar photovoltaics. It offers automated metrology systems that provide optical critical dimension, thin film metrology, and wafer stress for transistor and interconnect metrology applications; the Lynx cluster metrology platform for use in wafer metrology applications, including optical critical dimension, overlay, and thin film process control; and integrated metrology systems, which provide near real-time measurements. The company's automated and integrated systems are also used in various process control applications, including dimension and film thickness measurement, device topography, and defect inspection, as well as used in the analysis of other film properties, such as optical, electrical, and material characteristics. Its process control solutions are deployed in the fabrica tion process from front-end-of-line substrate manufacturing to high-volume production of semiconductors and other devices, and to wafer-scale packaging applications. The company sells its metrology and inspection systems directly and through original equipment manufacturer channels to semiconductor manufacturers and equipment suppliers, and producers of high-brightness-LEDs, solar photovoltaics, data storage devices, silicon wafers, and photomasks worldwide. Nanometrics Incorporated was founded in 1975 and is headquartered in Milpitas, California.

Advisors' Opinion:

• [By Steve Symington]

  What:�Shares of Nanometrics Incorporated� (NASDAQ: NANO  ) �popped more than 10% during Wednesday's intraday trading, then settled to close up 7% after the company turned in better-than-expected fourth quarter earnings.�

Top 5 Low Price Companies To Buy Right Now: Omnicom Group Inc.(OMC)

Omnicom Group Inc., together with its subsidiaries, provides advertising, marketing, and corporate communications services. It offers services in traditional media advertising, customer relationship management, public relations, and specialty communications groups. The company?s services include advertising, brand consultancy, corporate social responsibility consulting, crisis communications, custom publishing, database management, digital and interactive marketing, direct marketing, directory advertising, entertainment marketing, environmental design, experiential marketing, field marketing, financial/corporate business-to-business advertising, graphic arts, healthcare communications, and instore design. Omnicom Group also offers investor relations, marketing research, media planning and buying, mobile marketing services, multi-cultural marketing, non-profit marketing, organizational communications, package design, product placement, promotional marketing, public affairs, public relations, recruitment communications, reputation consulting, retail marketing, search engine marketing, and sports and event marketing services. It offers its services in the Americas, Europe, the Middle East, Africa, Asia, and Australia. The company was founded in 1944 and is based in New York, New York.

Advisors' Opinion:

• [By Sue Chang and Ben Eisen]

  OMC: An announcement by European Union regulators cleared the way for advertising powerhouses Omnicom Group Inc. (OMC) �and rival Publicis Groupe SA (PUBGY) (PGPEF) � (FR:PUB) to merge. The combined firm is expected to be the world�� largest advertising agency. Shares of Omnicom Group were up 1.4%.

• [By Seth Jayson]

  Calling all cash flows
  When you are trying to buy the market's best stocks, it's worth checking up on your companies' free cash flow once a quarter or so, to see whether it bears any relationship to the net income in the headlines. That's what we do with this series. Today, we're checking in on Omnicom Group (NYSE: OMC  ) , whose recent revenue and earnings are plotted below.

Top 5 Low Price Companies To Buy Right Now: Patterson Companies Inc.(PDCO)

Patterson Companies, Inc. operates as a distributor serving the dental, companion-pet veterinarian, and rehabilitation supply markets in North America. Its Dental Supply segment provides consumable dental supplies, such as x-ray film and solutions; impression and restorative materials; hand instruments; sterilization products; anesthetics; infection control products, including protective clothing, gloves, and facemasks; paper, cotton, and disposable products; toothbrushes; dental accessories; printed office products, office filing supplies, and practice management systems; x-ray machines, handpieces, dental chairs and handpiece control units, diagnostic equipment, dental lights, compressors, chair-side restoration systems, and inter-oral cameras; practice management and clinical software; hardware and networking solutions; and patient education solutions. The company?s Veterinary Supply segment offers consumable supplies, such as lab supplies, paper goods, needles and syr inges, gauze and wound dressings, sutures, latex gloves, and orthopedic and casting products; pharmaceuticals comprising anesthetics, antibiotics, ointments, and nutraceuticals; diagnostics; biologicals, including vaccines and injectibles; and equipment and software. Its Rehabilitation Supply segment provides dressing and grooming devices, and toileting, dining, and bathing aids; braces, splints, and orthotics; exercise bands, putty, weight balls, and mats; walkers, canes, and wheelchair accessories; rolls, wedges, seating and standers, and mobility assistance products; motor stimulation products; products for heating and cooling therapies, electrical stimulation, laser, ultrasound, paraffin, iontophoresis, and therapeutic creams and lotions; and rehabilitation equipment and software. The company was formerly known as Patterson Dental Company and changed its name to Patterson Companies, Inc. in June 2004. Patterson Companies, Inc. was founded in 1877 and is based in St. Paul , Minnesota.

Advisors' Opinion:

• [By Seth Jayson]

  Patterson Companies (Nasdaq: PDCO  ) reported earnings on May 23. Here are the numbers you need to know.

  The 10-second takeaway
  For the quarter ended April 27 (Q4), Patterson Companies met expectations on revenues and met expectations on earnings per share.

• [By Eric Volkman]

  Patterson (NASDAQ: PDCO  ) has elected not to raise its quarterly shareholder payout. The company today declared a regular stock dividend of $0.16 per share, to be paid on July 26 to shareholders of record as of July 11. That amount matches the company's previous distribution, which was paid at the end of April. Before that, Patterson handed out $0.14 per share.